Dcm Shriram Bio Enchem Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 07-11-2024
- Paid Up Capital ₹ 2.76 Cr
as on 07-11-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Dcm Shriram Bio Enchem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajay Shriram, Vikram Shriram, Ajit Shriram, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299DL2022PLC394998
- Company No.
394998
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2022
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dcm Shriram Bio Enchem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Shriram  | Director | 11-Mar-2022 | Current |
| Vikram Shriram | Director | 11-Mar-2022 | Current |
| Ajit Shriram | Director | 11-Mar-2022 | Current |
| Krishan Sharma | Director | 18-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Dcm Shriram Bio Enchem.
Dcm Shriram Bio Enchem Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dcm Shriram Bio Enchem?
In 2023, Dcm Shriram Bio Enchem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dcm Shriram LimitedActive 35 years 10 monthsAjay Shriram, Vikram Shriram and 2 more are mutual person
- Dcm Shriram Aqua Foods LimitedActive 31 years 11 months
Ajay Shriram and Vikram Shriram are mutual person
- Shriram Agsmart LimitedActive 2 years 5 months
Ajay Shriram, Vikram Shriram and 2 more are mutual person
- Dcm Shriram Prochem LimitedActive 2 years 9 months
Ajay Shriram, Vikram Shriram and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dcm Shriram Bio Enchem?
Unlock and access historical data on people associated with Dcm Shriram Bio Enchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dcm Shriram Bio Enchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dcm Shriram Bio Enchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
